IBI-334

• Target :

  EGFR|||Immunology/Inflammation related

• Related Pathways :

  JAK/STAT signaling|||Angiogenesis|||Immunology/Inflammation|||Tyrosine Kinase/Adaptors

• Bioactivity :

  IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C